Phosphoproteomics sample handling

Phosphates start leaving the moment cells lyse. Phosphatases are built to remove them, and some buffers remove them chemically as well. Phosphoproteomics sample handling is the discipline of staying ahead of both losses, then enriching the peptides that remain, then refusing to name a residue the fragments cannot place. Bottom-up proteomics in plain language explains ordinary identification. A phosphate adds a modification mass and a handling emergency the ordinary digest does not have.

Enzymatic loss and chemical loss

In an intact cell, phosphorylation is a balance of kinases and phosphatases. Lysis throws that balance toward the phosphatases unless you stop them. Broad inhibitor mixtures aimed at serine and threonine phosphatases, and others aimed at tyrosine phosphatases, are the usual reagent classes. They belong in the lysis buffer before the cells break, at the concentration and contact time the product describes. Adding them to a lysate that has already sat at room temperature records the phosphatases' work, not the cell's.

Chemical loss is separate. Phosphoserine and phosphothreonine can undergo beta-elimination in harsh alkaline conditions, and heat accelerates damage. A long, warm, high-pH step that was harmless for a plain proteome can strip the modification you intended to measure. Tyrosine phosphates are a different chemical personality and a much lower abundance class in many cells. They are not protected by a serine-phosphatase habit alone. Match the inhibitor class and the enrichment class to the residue you will claim.

Cold handling and speed are the principle that sits under both problems. Work on ice, pre-chill tubes, and move from lysis to denaturation without a queue of other tasks. Storing biological samples from fridge to freezer is the right companion if the sample must wait. A wait in denaturant with inhibitors is a different object from a wait as a native lysate.

Denature, then digest, without cooking the phosphate

Alkylation and trypsin still happen. Cysteines still need a defined chemistry if the search assumes one. The enemy is the extra warm time, not the existence of a digest. Many protocols reduce and alkylate in urea or another chaotrope in the cold, dilute to a trypsin-tolerant denaturant strength, and digest at about 37 Celsius for the time the enzyme supplier states. Treat those temperatures and times as the protocol's, not as a universal recipe. A shorter digest that the supplier allows is often kinder to a labile modification than an unattended overnight hold that wandered in temperature.

Urea must stay cold here for two reasons. Warm urea carbamylates lysines, which both blocks cleavage and adds a mass. And a warm step is exactly what you are trying to keep rare. Guanidinium salts inhibit trypsin strongly, so if you dissolve in them you must dilute or exchange before the enzyme, again on the protocol's terms. Detergents used to lyse cells have to be compatible with the later enrichment or removed by a class that does not also throw the phosphopeptides away.

Stop the digest by acidifying as the method describes. Then desalt if the enrichment chemistry requires it. A salty, detergent-laden digest will fail at the enrichment resin even when the phosphates survived.

Enrichment classes, after the digest

Metal-affinity resins, often iron or gallium immobilised on a chelator, and metal oxides such as titanium dioxide or zirconium dioxide, bind phosphate groups on peptides. Phospho-specific antibodies, most often used for phosphotyrosine because that mark is scarce, are a third class. All of them enrich peptides. They do not enrich equally. Acidic peptides that are not phosphorylated can bind some resins, which is why wash conditions are the method rather than a rinse. Elution has to release phosphopeptides without destroying them.

Enrichment does not measure stoichiometry. You have concentrated the modified peptides relative to the unmodified majority. The unmodified copies were mostly washed away, so the eluate cannot tell you the occupancy on the protein. If occupancy is the question, you need a design aimed at it. If a localised site list is the question, enrichment is appropriate and the amount of starting material has to be larger than for a plain shotgun injection of the same proteome. How much larger depends on the chemistry and the abundance of the sites. Ask for a range matched to the method. Do not invent a single mass that every study should weigh out.

A failed enrichment and a true biological absence look the same in an empty table. Include a control peptide or a sample you know is phosphorylated, so an empty eluate can be blamed on the resin, the washes or the input amount.

A site needs localisation, not only a mass

The search can allow phosphorylation as a variable modification and return a peptide with the right extra mass. That peptide may contain several serines, threonines or tyrosines. The mass is compatible with a phosphate on any of them. Site localisation uses fragment ions that include one candidate residue and exclude another. Tools summarise that evidence as a site probability, an Ascore-style value, or an equivalent the software documents. Report the score class and the cutoff you accepted.

Below that cutoff, the honest row is "phosphorylated peptide, site ambiguous". Collapsing ambiguity onto the residue that fits the story is how false sites enter a paper. UniProt may already list a site from other studies. Agreement with that list is comforting and is not a substitute for fragments in your spectrum. PeptideAtlas can show whether a phosphopeptide has been seen widely. It is background, not your localisation score.

Loss of signal, or a failure to enrich

protocols.io and method sections in PRIDE show how different groups order inhibitors, digestion and enrichment. Read them for the order of operations. Follow the protocol tied to the resin in your hand.

Safety and research meaning

Phosphatase inhibitor mixtures, metal salts, acids and the organic solvents of enrichment are chemical hazards. Use the safety data sheet for the bottle you open, and dispose of metal-containing waste as your institution asks. A phosphosite list is a research observation about peptides. It is not a clinical biomarker result and not proof that a kinase caused a phenotype. Biosafety of the cells is an institutional decision, identical in kind to any other lysate. Localising a phosphate does not change the containment.

A power cut during the cold spin

The vulnerable moment is a refrigerated centrifuge that stops mid-run when the power fails, then sits. The rotor warms, the lysate warms, and phosphatases that were only slowed by temperature start again if the proteins are still native. Plan this before it happens. Get the sample into denaturant and inhibitors at lysis, so a delay is a delay of an already stopped mixture, not of a living extract. If the power fails before that, move tubes onto ice or validated cold packs, and do not leave them in a warming rotor while you look for an extension cord. When the power returns, do not resume and pretend the temperature history was continuous. Note the gap, and if the lysate was native during it, treat the phosphorylation pattern as compromised. A generator plan or a sister cold centrifuge is an institutional matter. The bench plan is: denature first, and never let a native phospholysate wait in the warm.

What the enquiry must distinguish

Ask whether the study needs localised sites or only a protein-level suggestion that phosphorylation is present. Those are different evidence standards and different amounts of material. Name the residue class, serine and threonine versus tyrosine, because antibody enrichment and metal enrichment are not interchangeable defaults. Name the starting amount as a class and say that enrichment needs more than a plain digest. Name inhibitors already in the lysis buffer and any detergent the resin will not tolerate.

The method can be discussed against the shotgun discovery proteomics reference, the protein identification by LC-MS/MS reference and the differential abundance reference if sites will be compared across conditions. Put the handling constraints in the quote request. The useful reply names an enrichment class, a localisation standard and an amount class. It does not need to pretend that every phosphate in the cell will be recovered.